Skip links

Our First Product

The NEURVESTA wearable device allows clinicians to screen for impairments to the vestibular balance system and then apply corrective neurostimulation to help restore disrupted balance.

The NEURVESTA device and related services are positioned to become the cornerstone of an aging-in-place market already valued at $150B per year in the U.S. alone.

The NEURVESTA device is currently available for research use only.

NEURVESTA expands access to comprehensive personalized care for tens of millions of people with balance disruptions.

Picture1 (Large)

Vestibular specialists

NEURVESTA bridges the wide gap between demand vs. availability of vestibular specialists who can diagnose and treat balance disruptions.

Clinical neurologists

NEURVESTA bridges the wide gap between demand vs. availability of clinical neurologists who can diagnose and treat balance disruptions.

Rehabilitation providers

NEURVESTA allows rehab providers to deliver more comprehensive personalized care for patients with balance disruptions.

Primary care providers

NEURVESTA allows primary care providers to deliver more comprehensive personalized care for patients with balance disruptions.

Physical therapists

NEURVESTA allows physical therapy providers to deliver more comprehensive personalized care for patients with balance disruptions.

Balance impaired

NEURVESTA expands access to comprehensive personalized diagnoses and treatments for tens of millions of people with balance disruptions.

Contact Us

Learn more about Neursantys R&D collaborations, pilot deployments, and employment opportunities.

Contact Us
🍪 This website uses cookies to improve your web experience.